January 2008

Cover Story
Geisinger’s “warranty” for CABG surgery has gotten a lot of attention, but is it transplantable?

Frank Diamond

Here are some of the challenges that health insurers face this year

Peter Kongstvedt, MD

We’ve made strides in increasing the transparency of pricing in the pharmacy supply chain, and now we need to change dispensing behavior

Thomas Kaye, RPh, MBA

Tougher standards being applied by insurers spur debate about what constitutes true value in a new drug

John Carroll

By assisting doctors, insurers can get all the payment that they are due, but that too often is lost

Marcia Naveh, MD

Peer-Reviewed

Mary V. Mason, MD, MBA ; Kara M. House, MBA ; Janice Linehan, PA-C, MHP ; Carol A. Speers, RN ; Lisa M. Joseph, RN, MBA

Editor's Memo

John A. Marcille

Viewpoint
As an idea, Geisinger’s ProvenCare program is a winner. What happens in the marketplace remains to be seen.

Michael L. Millenson

Medication Management
Although federal health agencies support the idea of having pharmacists administer vaccines to their patients, the roadblock continues to be a question of payment

Martin Sipkoff

Tomorrow’s Medicine
Heart valves made from new composite materials minimize calcification, a common problem that can lead to a second valve replacement

Thomas Morrow, MD